Acacia Research Corporation 13D and 13G filings for Evofem Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-06-09 5:29 pm Purchase | 2020-06-04 | 13G | Evofem Biosciences, Inc. EVFM | ACACIA RESEARCH CORP ACTG | 1 0.002% | 1 (New Position) | Filing |